Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist
about
Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteriesThromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartanThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsThromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus.Operational correlates of prostanoid TP receptor expression in human non-pregnant myometrium are unaffected by excision site or menstrual cycle status of the donor.Thromboxane A2 agonist modulation of excitatory synaptic transmission in the rat hippocampal slice.Brain-penetrant tetrahydronaphthalene thromboxane A2-prostanoid (TP) receptor antagonists as prototype therapeutics for Alzheimer's disease.The Gordon Wilson Lecture. Regulation of thromboxane A2 receptors by testosterone: implications for steroid abuse and cardiovascular disease.Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2Roles of affinity and lipophilicity in the slow kinetics of prostanoid receptor antagonists on isolated smooth muscle preparations.Reconstitution of thromboxane A2 receptor-stimulated phosphoinositide hydrolysis in isolated platelet membranes: involvement of phosphoinositide-specific phospholipase C-beta and GTP-binding protein Gq.
P2860
Q28280471-7318FF9A-5437-4496-8C8D-9D493656D8ECQ28365334-AB4F7D91-B0CA-4781-886F-6DBEEB5E3E58Q30486707-CC4D03E8-74FC-4707-9794-45FBB14B2641Q33908644-59BFC9C5-A2D6-452A-8A6C-F6BDD109269FQ34777113-59DDCF40-0B66-47A2-BB88-385F4C8E648FQ35041785-2D9BD28F-EBDB-4ECE-A240-ECE31EE31624Q35874154-5B634FC9-6B7D-4633-A386-0AA0809E50E2Q36415271-C7D2E43B-E604-4FD8-B028-510C3B728D0EQ36647648-A158C2ED-6398-4FE1-B342-FEBCE16D3A40Q37388131-10E1F83B-448D-40BC-B4D9-F70F80274F64Q41984226-4BECCE9A-B4F0-4BC0-91A7-3AAA15EE0B33Q42188513-F055B09B-F227-4673-B053-B779A408AE09
P2860
Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist
description
1989 nî lūn-bûn
@nan
1989 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist
@ast
Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist
@en
Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist
@nl
type
label
Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist
@ast
Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist
@en
Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist
@nl
prefLabel
Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist
@ast
Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist
@en
Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist
@nl
P2093
P1476
Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist
@en
P2093
P R Mayeux
P V Halushka
T A Morinelli
P304
P407
P577
1989-11-01T00:00:00Z